$FTRP (CSE) / $FTRPF (US OTC)
Field Trip Health is forming a nice stair step pattern. It appears that given current market conditions the stock is moving sideways before taking the next step up.
Field Trip is also expanding their brick & mortar psychedelic therapy network to 75 clinic locations in the coming few years. With 6 clinics that are currently operational they have demonstrated the ability to generate revenues through assisted Ketamine therapy treatments.
Given the expanding scope of psychedelic substances with the potential to treat depression, anxiety, eating disorders - not mention the potential benefits to related to neurological diseases.
Recently organized the largest bought deal in the psychedelic sector of any stock that is currently trading. With that money came institutional backers and investments from pharma companies.
KEY POINTS
- Low Float of aprx. 60 million outstanding shares
- Revenues around $1.2 million per year
- Revenue growth of 235% quarter of quarter
- Proven revenue streams and income strategy
- Currently operating 6 international clinics
- Plans to open 75 clinics over 2 years
- Novel psychedelic compound under development
- Largest bought deal in sector $92 million dollars
- Deals only in legal substances ** Up-listing Potential **
- Currently operating in 4 countries
- Partnership with MAPS using Field Trip Clinics
POTENTIAL CATALYSTS
- Health Canada Special Access Program
- Starting Phase 1 clinical trials on FT-104
- Relaxing laws surrounding psychedelic substances
- Increasing revenues in current treatment centers
- Adding additional revenue with each new center
- Positive results MDMA trials with MAPS
VIEW THE CHART
https://twitter.com/love_money_guru/status/1381788492187992064
Submitted April 12, 2021 at 09:58PM by love_money_guru https://ift.tt/3dd2dox
